These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7719323)

  • 21. Radioimmunoimaging diagnosis of human bladder carcinoma.
    Yu LZ; Gu FL; Zhang CL
    Scand J Urol Nephrol Suppl; 1994; 157():13-7. PubMed ID: 7939444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preparation and application of the monoclonal antibody against hepatoma-specific gamma-glutamyltransferase].
    Tang W; Wang XY; Gao JE; Ji HP; Tao QM; Ji Y
    Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):100-2. PubMed ID: 12648407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computed tomographic findings of invasive transitional cell carcinoma in the kidney.
    Fukuya T; Honda H; Nakata H; Egashira K; Watanabe H; Naitou S; Kumazawa J; Masuda K
    Radiat Med; 1994; 12(1):6-10. PubMed ID: 8016405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of 99mTc-anti-CEA immunoscintigraphy in patients with liver metastases from colorectal carcinoma.
    Bock E; Becker W; Scheele J; Wolf F
    Nuklearmedizin; 1992 Jun; 31(3):80-3. PubMed ID: 1641359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoscintigraphy using 99mTc-labeled anti-CEA monoclonal antibody for patients with colorectal cancer.
    Takenoshita S; Hashizume T; Asao T; Nakamura J; Katoh R; Oriuchi N; Ootake H; Inoue T; Watanabe N; Endo K
    Anticancer Res; 1995; 15(2):471-5. PubMed ID: 7763024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computed tomography in the diagnosis and management of the renal mass.
    Mauro MA; Balfe DM; Stanley RJ; Weyman PJ; Lee JK; McClennan BL
    JAMA; 1982 Dec; 248(21):2894-6. PubMed ID: 7143658
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunoscintigraphy of carcinomas in the area of the head-neck with technetium-99m marked monoclonal antibody 174H.64. A new diagnostic procedure].
    Kiefer J; Baum RP; Knecht R; Hertel A; Niesen A; von Ilberg C; Hör G
    HNO; 1994 Sep; 42(9):546-52. PubMed ID: 7989226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MAb 170H.82: an evaluation of a novel panadenocarcinoma monoclonal antibody labelled with 99Tcm and with 111In.
    McEwan AJ; MacLean GD; Hooper HR; Sykes T; McQuarrie SA; Golberg L; Bodnar DM; Lloyd SL; Noujaim AA
    Nucl Med Commun; 1992 Jan; 13(1):11-9. PubMed ID: 1594163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An algorithmic approach to the diagnosis and staging of renal neoplasms.
    Lang EK
    Radiol Clin North Am; 1986 Dec; 24(4):683-94. PubMed ID: 3786691
    [No Abstract]   [Full Text] [Related]  

  • 30. Localization of 131I-labeled antibodies in human renal cell carcinomas and in a mouse hepatoma and correlation with tumor detection by photoscanning.
    Ghose T; Norvell ST; Aquino J; Belitsky P; Tai J; Guclu A; Blair AH
    Cancer Res; 1980 Aug; 40(8 Pt 2):3018-31. PubMed ID: 7397696
    [No Abstract]   [Full Text] [Related]  

  • 31. Determination of telomerase activity for differential analysis of multifocal renal cell carcinomas.
    Fiedler W; Junker K; Schlichter A; Schubert J; Ernst G; Dahse R; Claussen U
    Kidney Int; 1999 Oct; 56(4):1286-8. PubMed ID: 10504476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal pelvic carcinoma. An angiographic re-evaluation.
    Rabinowitz JG; Kinkhabwala M; Himmelfarb E; Robinson T; Becker JA; Bosniak M; Madayag MM
    Radiology; 1972 Mar; 102(3):551-4. PubMed ID: 5060156
    [No Abstract]   [Full Text] [Related]  

  • 33. A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma.
    Dagnaes-Hansen F; Rasmussen LM; Tilton R; Denner L; Flyvbjerg A
    Anticancer Res; 2003; 23(2B):1625-30. PubMed ID: 12820432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of glutathione s-transferase alpha in clear cell renal cell carcinoma.
    Chuang ST; Chu P; Sugimura J; Tretiakova MS; Papavero V; Wang K; Tan MH; Lin F; Teh BT; Yang XJ
    Am J Clin Pathol; 2005 Mar; 123(3):421-9. PubMed ID: 15716239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunolocalisation of an anti-EMA monoclonal antibody to a renal carcinoma xenograft.
    Yiu CY; Baker LA; Boulos PB
    Anticancer Res; 1990; 10(6):1775-8. PubMed ID: 2285258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoscintigraphy: Importance for researchers and patients.
    Britton KE; Granowska M
    Acta Oncol; 1996; 35(3):313-7. PubMed ID: 8679262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C. T. evaluation of renal space occupying lesions.
    Baert AL; Marchal G; Staelens B; Coenen Y
    Rofo; 1977 Apr; 126(4):285-91. PubMed ID: 140118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computed tomography of the kidney.
    Sandler CM; Raval B; David CL
    Urol Clin North Am; 1985 Nov; 12(4):657-75. PubMed ID: 2997968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunoscintigraphy in colorectal cancers from the viewpoint of the gastroenterologist].
    Dippold WG; Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1990 Dec; 28(12):673-7. PubMed ID: 2087823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spiral CT of the kidneys: role in characterization of renal disease. Part II: Neoplastic disease.
    Wyatt SH; Urban BA; Fishman EK
    Crit Rev Diagn Imaging; 1995; 36(1):39-72. PubMed ID: 7748485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.